Compare Hims and Hers Health Inc (HIMS) vs Kroger Co (KR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Kroger Co — how do they compare? Hims and Hers Health Inc trades at $29.35 (market cap $6.55B), while Kroger Co trades at $61.09 (market cap $36.27B). The key difference: Kroger Co is far larger — about 5.5× Hims and Hers Health Inc's market cap, and Kroger Co pays a 2.54% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and Kroger Co for 108 Days on average.
| HIMS | KR | |
|---|---|---|
Market Cap | $6.55B | $36.27B |
Volume | 14,842,814 | 8,301,523 |
Sector | Health | Consumer Staples |
52-Week High | $62.76 | $75.60 |
52-Week Low | $14.52 | $55.53 |
Typical Hold Time | 21 Days | 108 Days |
Enterprise Value | $7.25B | $57.69B |
Dividend Yield | — | 2.54% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health (HIMS) trades at $29.38, down 0.54% on the day, amid a bearish technical signal and mixed earnings history. The company reported revenue of $2.35 billion in 2025 with a net income of $128.37 million, but 2026 projections show a net loss of $142 million. Valuation ratios are elevated with a P/E of 57.14 and EV/EBITDA of 205.86. Recent news highlights multiple securities class action lawsuits filed against the company, creating investor uncertainty.
The outlook is cautious due to profitability concerns and legal risks. Analyst consensus is a Hold with a $32.17 price target, suggesting limited upside. Key risks include ongoing litigation, negative profit margins, and high valuation multiples. Investment appeal hinges on the company's ability to return to profitability and navigate regulatory challenges.
Kroger (KR) trades at $59.25, up 1.44% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating expectations but Q1 2026 missing. Fundamentals reveal strong revenue of $147.12B (2025) but thin net margins of 0.73%, while valuation metrics like P/S of 0.26 appear attractive. Recent news highlights digital growth initiatives and a pending Giant Eagle acquisition.
Outlook: KR offers value with low P/S and analyst consensus target of $70.62 (19% upside). Opportunities include e-commerce expansion and cost efficiencies. Risks involve integration challenges from acquisitions, competitive pressures, and softer sales guidance. Cash flow trends show volatility, with 2026 projecting negative net cash flow.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Kroger Co
Kroger is the leading American grocer, with 2,726 supermarkets operating under several banners throughout the country as of the end of fiscal 2021. Around 83% of stores have pharmacies, while nearly 60% also sell fuel. The company also operates roughly 120 fine jewelry stores. Kroger features a leading private-label offering and manufactures around 30% of its own-brand units (and more than 40% of its grocery own-label assortment) itself, in 33 food production plants nationwide. Kroger is a top-two grocer in most of its major markets (as of early 2021, according to company data). Virtually all of Kroger's sales come from the United States.
Read more on KR →
